Syndecan-1 in the Tumor Microenvironment

被引：7
|
作者：
Handra-Luca, Adriana [1 ,2 ]
机构：
[1] Univ Sorbonne Paris Nord, Serv Anat Pathol, Bobigny, France
[2] Univ Sorbonne Paris Nord, APHP GHU Avicenne, Bobigny, France
来源：
TUMOR MICROENVIRONMENT: EXTRACELLULAR MATRIX COMPONENTS - PT B | 2020年 / 1272卷
关键词：
Syndecan-1; Tumor; Stroma; Microenvironment; Pathology; Microscopy; Immunohistochemistry; Fibroblast; Vessels; Inflammatory cells; Extracellular matrix; Adenocarcinoma; Squamous cell carcinoma; Morphotype; Prognosis; STROMAL FIBROBLASTS; PROGNOSTIC VALUE; EXPRESSION; CELLS; CARCINOMAS; MYELOMA;
D O I：
10.1007/978-3-030-48457-6_3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Syndecan-1 along with the other three syndecan proteins is present in the varied components of the tumor microenvironment: fibroblasts, inflammatory tumor immunity-associated cells, vessels, and extracellular matrix. Epithelial and non-epithelial tumors may show stromal syndecans. The main relevance of stromal syndecans as tumor biomarker resides in the relationships to tumor features such as type and differentiation as well as to prognosis.
引用
收藏
页码：39 / 53
页数：15
相关论文
共 50 条
  • [1] Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
    Chute, Colleen
    Yang, Xinhai
    Meyer, Kristy
    Yang, Ning
    O'Neil, Keelin
    Kasza, Ildiko
    Eliceiri, Kevin
    Alexander, Caroline
    Friedl, Andreas
    BREAST CANCER RESEARCH, 2018, 20
  • [2] Syndecan-1: a dynamic regulator of the myeloma microenvironment
    Ralph D. Sanderson
    Yang Yang
    Clinical & Experimental Metastasis, 2008, 25 : 149 - 159
  • [3] Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis
    Andersen, Niels F.
    Kristensen, Ida B.
    Preiss, Birgitte S.
    Christensen, Jacob H.
    Abildgaard, Niels
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) : 211 - 217
  • [4] Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
    Colleen Chute
    Xinhai Yang
    Kristy Meyer
    Ning Yang
    Keelin O’Neil
    Ildiko Kasza
    Kevin Eliceiri
    Caroline Alexander
    Andreas Friedl
    Breast Cancer Research, 20
  • [5] Syndecan-1: a dynamic regulator of the myeloma microenvironment
    Sanderson, Ralph D.
    Yang, Yang
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (02) : 149 - 159
  • [6] Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma
    Szumilo, Justyna
    Burdan, Franciszek
    Zinkiewicz, Krzysztof
    Dudka, Jaroslaw
    Klepacz, Robert
    Dabrowski, Andrzej
    Korobowicz, Elzbieta
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2009, 47 (04) : 571 - 578
  • [7] Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size
    Malek-Hosseini, Zahra
    Jelodar, Sina
    Talei, Abdolrasoul
    Ghaderi, Abbas
    Doroudchi, Mehrnoosh
    BREAST CANCER, 2017, 24 (06) : 742 - 747
  • [8] Aberrant Expression of Syndecan-1 in Cervical Cancers
    Karaszi, Katalin
    Vigh, Renata
    Mathe, Miklos
    Fullar, Alexandra
    Olah, Laszlone
    Fule, Tibor
    Papp, Zoltan
    Kovalszky, Ilona
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2255 - 2264
  • [9] Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment
    Dhodapkar, MV
    Sanderson, RD
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 35 - 43
  • [10] A prognostic value of syndecan-1 in gastric cancer
    Wiksten, JP
    Lundin, J
    Nordling, S
    Kokkola, A
    Haglund, C
    ANTICANCER RESEARCH, 2000, 20 (6D) : 4905 - 4907
12345